ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
18.720,01
-1,47%
S&P 500
5.702,55
-0,19%
Dow Jones
42.063,36
0,09%
Euro vs US Dollar
1,11705
-0,04%
Bitcoin
63.269,48
0,10%
Registration Strip Icon for discussion Registrieren Sie sich, um in unseren aktiven Foren mit gleichgesinnten Anlegern zu diskutieren.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. NASDAQ
  6. Cytek Biosciences Inc (CTKB)

  7. Cytek Biosciences Inc (CTKB) News

CTKB

Cytek Biosciences (CTKB)

Cytek Biosciences Inc
Von:
Sortieren nach:
 Showing the most relevant articles for your search:NASDAQ:CTKB
DatumZeitQuelleÜberschriftSymbolFirma
18/09/202423h00GlobeNewswire Inc.Cytek® Biosciences Brings Full Spectrum Profiling™ (FSP™) Technology to the Forefront at Major Clinical Conferences in the U.S. and EuropeNASDAQ:CTKBCytek Biosciences Inc
17/09/202400h26Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CTKBCytek Biosciences Inc
12/09/202421h20GlobeNewswire Inc.Cytek Announces Resignation of Chief Operating Officer Chris WilliamsNASDAQ:CTKBCytek Biosciences Inc
12/09/202412h04Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:CTKBCytek Biosciences Inc
22/08/202400h26Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CTKBCytek Biosciences Inc
22/08/202400h24Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CTKBCytek Biosciences Inc
22/08/202400h22Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CTKBCytek Biosciences Inc
22/08/202400h21Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CTKBCytek Biosciences Inc
22/08/202400h19Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CTKBCytek Biosciences Inc
22/08/202400h15Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CTKBCytek Biosciences Inc
21/08/202423h00GlobeNewswire Inc.Cytek® Biosciences Achieves ISO 13485 Certification at San Diego Reagent Manufacturing FacilityNASDAQ:CTKBCytek Biosciences Inc
08/08/202422h05GlobeNewswire Inc.Cytek Biosciences to Participate in Upcoming Investor ConferencesNASDAQ:CTKBCytek Biosciences Inc
06/08/202423h16Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:CTKBCytek Biosciences Inc
06/08/202422h16Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:CTKBCytek Biosciences Inc
06/08/202422h05GlobeNewswire Inc.Cytek Biosciences Reports Second Quarter 2024 Financial ResultsNASDAQ:CTKBCytek Biosciences Inc
30/07/202423h00GlobeNewswire Inc.Cytek® Biosciences Automates Panel Design with New Intelligent AlgorithmNASDAQ:CTKBCytek Biosciences Inc
30/07/202422h05GlobeNewswire Inc.Cytek Biosciences to Report Second Quarter 2024 Financial Results on August 6, 2024NASDAQ:CTKBCytek Biosciences Inc
11/06/202422h02Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:CTKBCytek Biosciences Inc
08/06/202401h03Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CTKBCytek Biosciences Inc
08/06/202400h53Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CTKBCytek Biosciences Inc
06/06/202414h00GlobeNewswire Inc.Cytek Biosciences Announces $50 Million Stock Repurchase ProgramNASDAQ:CTKBCytek Biosciences Inc
31/05/202422h48Edgar (US Regulatory)Form SD - Specialized disclosure reportNASDAQ:CTKBCytek Biosciences Inc
30/05/202422h05GlobeNewswire Inc.Cytek Biosciences to participate at the Goldman Sachs 45th Annual Global Healthcare ConferenceNASDAQ:CTKBCytek Biosciences Inc
28/05/202423h30GlobeNewswire Inc.1-Laser and 2-Laser 6-Color TBNK Reagents from Cytek® Biosciences Approved for Clinical Use in ChinaNASDAQ:CTKBCytek Biosciences Inc
23/05/202400h41Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CTKBCytek Biosciences Inc
23/05/202400h36Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CTKBCytek Biosciences Inc
23/05/202400h34Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CTKBCytek Biosciences Inc
23/05/202400h32Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CTKBCytek Biosciences Inc
23/05/202400h31Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CTKBCytek Biosciences Inc
23/05/202400h28Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CTKBCytek Biosciences Inc
 Showing the most relevant articles for your search:NASDAQ:CTKB

Kürzlich von Ihnen besucht

AMEX
XLE
Energy Select Sector SPDR
CCOM
US30
US 30
TG
NOV
Novo Nordisk
COIN
SOLUSD
Solana
COIN
ADAUSD
Cardano
NASDAQ
NVDA
NVIDIA
NYSE
DIS
Walt Disney
NYSE
NKE
Nike
AMEX
SPY
SPDR S&P 500
COIN
ETHUSD
Ethereum
USOTC
RHHBY
Roche (QX)
NYSE
MCD
McDonalds
COIN
AVAXUSD
Avalanche
NYSE
XOM
Exxon Mobil
AMEX
XLF
Financial Select Sector
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2024 ADVFN PLC - Alle Rechte vorbehalten